HK$34.14
3.29%
Hong Kong, Oct 02, 04:08 pm HKT. Closed.
ISIN
KYG549581067
Symbol
3692
Index

Hansoh Pharmaceutical Group Company Stock price

HK$34.14
-0.98 2.79% 1M
-5.22 13.26% 6M
-1.94 5.38% YTD
-3.82 10.06% 1Y
+23.48 220.26% 3Y
+14.42 73.12% 5Y
+14.64 75.08% 10Y
+14.64 75.08% 20Y
Hong Kong, Closing price Fri, Oct 02 2026
-1.16 3.29%
ISIN
KYG549581067
Symbol
3692
Index
Industry

Is Hansoh Pharmaceutical Group Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$214.1b
Enterprise Value
HK$175.3b
Net debt
positive
Cash
HK$43.8b
Shares outstanding
6.1b
Valuation
P/E
26.5
P/S | estimate
11.5 | 10.6
EV/Sales | estimate
9.4 | 8.6
EV/FCF | ex SBC
- | -
P/B
4.8
Dividends
DPS
HK$0.49
Yield 1Y | 5Y
1.4% | 1.4%
Growth 1Y | 5Y
32.2% | 44.5%
Payout 1Y | 3Y
44.5% | 46.1%
Increased
3 Years
Financials
Revenue | estimate
HK$18.6b | HK$20.3b
EBITDA
-
EBIT
HK$8.5b
Net Income
HK$7.8b
Free Cash Flow | ex SBC
- | -
Growth
Revenue | estimate
20.6% | 15.3%
EBITDA
-
EBIT
59.1%
Net Income
39.7%
Free Cash Flow
-
Margin
Gross
90.5%
EBITDA
-
EBIT
45.8%
Net
42.0%
Free Cash Flow | ex SBC
- | -
Financial Health
Equity Ratio
88.6%
Return on Equity
15.7%
ROCE
19.1%
ROIC
127.9%
Debt/Equity
0.1
More
EPS
HK$1.3
FCF per Share
-
Short interest
-
Employees
9k
Rev per Employee
HK$1.9m

Hansoh Pharmaceutical Group Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

27x Buy
93%
2x Hold
7%

Analyst Opinions

29 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

Buy
93%
Hold
7%

Financial data from Hansoh Pharmaceutical Group Company

Jun '26
+/-
%
18,608 18,608
21% 21%
100%
- Direct Costs 1,771 1,771
25% 25%
10%
16,837 16,837
20% 20%
90%
- Selling and Administrative Expenses 5,575 5,575
4% 4%
30%
- Research and Development Expense 4,280 4,280
24% 24%
23%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 8,523 8,523
59% 59%
46%
Net Profit 7,817 7,817
40% 40%
42%

In millions HKD.

Don't miss a Thing! We will send you all news about Hansoh Pharmaceutical Group Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.

Head office Cayman Islands
CEO Ms. Zhong
Employees 9,347
Founded 2015
Website www.hspharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today